Innoviva (INVA) vs Phibro Animal Health (PAHC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Innoviva (INVA) has outperformed Phibro Animal Health (PAHC) over the past year, gaining 20.1% versus a gain of 0.8%. Over five years, PAHC leads with a +71.6% price change compared with +25.6% for INVA. Phibro Animal Health is the larger company by market cap ($1.58 billion vs $1.53 billion), about 1.0 times the size.
On valuation, Innoviva trades at a lower forward P/E (9.6x vs 10.1x for Phibro Animal Health). Phibro Animal Health pays a dividend yielding 1.23%, while Innoviva does not currently pay one. Innoviva converts more of its revenue into profit, with a net margin of 65.9% versus 6.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INVA | PAHC |
|---|---|---|
| Share price | $21.16 | $38.97 |
| Market cap | $1.53B | $1.58B |
| 1-day change | +1.39% | +4.20% |
| YTD return | +4.40% | +0.11% |
| 1-year return | +20.15% | +0.78% |
| 5-year return | +25.65% | +71.56% |
| P/E ratio (TTM) | 4.94 | 16.04 |
| Forward P/E | 9.57 | 10.14 |
| EPS (TTM) | $4.28 | $2.43 |
| Dividend yield | 0.00% | 1.23% |
| Annual dividend | $0.00 | $0.48 |
| Revenue (latest FY) | $411.33M | $1.52B |
| Revenue growth (YoY) | +14.67% | +17.12% |
| Net income (latest FY) | $271.17M | $99.72M |
| Gross margin | 74.80% | 33.76% |
| Operating margin | 39.81% | 12.81% |
| Net margin | 65.92% | 6.57% |
| 52-week high | $25.15 | $60.08 |
| 52-week low | $16.52 | $28.25 |
| Distance from 52-week high | -15.86% | -35.14% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +65.41% | +12.91% |
| Average volume | 819.03K | 236.19K |
| Shares outstanding | 72.25M | 21.11M |
| Employees | 159 | 2,605 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- INVA has outperformed PAHC by 19.4 percentage points over the past year.
- Phibro Animal Health trades at a higher earnings multiple (16.0x vs 4.9x trailing P/E).
- Phibro Animal Health offers a meaningfully higher dividend yield (1.23% vs 0.00%).
- Innoviva is more profitable, keeping 65.9 cents of every revenue dollar as net income versus 6.6 cents for Phibro Animal Health.
About Innoviva
INVA stock →Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 159 employees
About Phibro Animal Health
PAHC stock →Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
Health Care · Biotechnology: Pharmaceutical Preparations · 2,605 employees
INVA vs PAHC FAQ
Which is bigger, Innoviva or Phibro Animal Health?
Phibro Animal Health (PAHC) is larger, with a market capitalization of $1.58B compared with $1.53B for Innoviva (INVA).
Which stock has performed better over the past year, INVA or PAHC?
INVA returned +20.15% over the past 12 months, compared with +0.78% for PAHC (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, INVA or PAHC?
INVA has the lower trailing P/E at 4.9, versus 16.0 for PAHC. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Innoviva or Phibro Animal Health?
Phibro Animal Health pays a dividend yielding 1.23%, while Innoviva does not currently pay a regular dividend.
Are Innoviva and Phibro Animal Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.